Evidence map›Paper›PMID 35806603›Full record

ArticleMaterials (Basel, Switzerland)2022

From Quantum Materials to Microsystems.

Riccardo Bertacco, Giancarlo Panaccione, Silvia Picozzi

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Tuning Topologically Nontrivial States in the BHT-Ni Metal-Organic Framework.The journal of physical chemistry. C, Nanomaterials and interfaces · 2025
    Article
  2. A Novel Ferroelectric Rashba Semiconductor.Advanced materials (Deerfield Beach, Fla.) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Riccardo BertaccoDipartimento di Fisica, Politecnico di Milano, 20133 Milan, Italy.ORCID 0000-0002-8109-9166
Giancarlo PanaccioneLaboratorio TASC in Area Science Park-Basovizza, CNR-IOM, 34149 Trieste, Italy.ORCID 0000-0003-0122-4041
Silvia PicozziConsiglio Nazionale delle Ricerche, CNR-SPIN c/o Università G. D'Annunzio, 66100 Chieti, Italy.ORCID 0000-0002-3232-788X

Funding

Ministry of Education, Universities and Research TWEET
6 · The paper itself

Abstract

The expression "quantum materials" identifies materials whose properties "cannot be described in terms of semiclassical particles and low-level quantum mechanics", i.e., where lattice, charge, spin and orbital degrees of freedom are strongly intertwined. Despite their intriguing and exotic properties, overall, they appear far away from the world of microsystems, i.e., micro-nano integrated devices, including electronic, optical, mechanical and biological components. With reference to ferroics, i.e., functional materials with ferromagnetic and/or ferroelectric order, possibly coupled to other degrees of freedom (such as lattice deformations and atomic distortions), here we address a fundamental question: "how can we bridge the gap between fundamental academic research focused on quantum materials and microsystems?". Starting from the successful story of semiconductors, the aim of this paper is to design a roadmap towards the development of a novel technology platform for unconventional computing based on ferroic quantum materials. By describing the paradigmatic case of GeTe, the father compound of a new class of materials (ferroelectric Rashba semiconductors), we outline how an efficient integration among academic sectors and with industry, through a research pipeline going from microscopic modeling to device applications, can bring curiosity-driven discoveries to the level of CMOS compatible technology.

Indexed as

ferroicsmicrosystemsquantum materials

Identifiers

PMID35806603
PMCPMC9267837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.